Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Expanding options of supportive care in IgA nephropathy.
Maixnerova D, Hartinger J, Tesar V Clin Kidney J. 2023; 16(Suppl 2):ii47-ii54.
PMID: 38053975 PMC: 10695500. DOI: 10.1093/ckj/sfad201.
Hydroxychloroquine in nephrology: current status and future directions.
Rao I, Kolakemar A, Shenoy S, Prabhu R, Nagaraju S, Rangaswamy D J Nephrol. 2023; 36(8):2191-2208.
PMID: 37530940 PMC: 10638202. DOI: 10.1007/s40620-023-01733-6.
References
1.
Yang Y, Chen P, Liu L, Cai Q, Shi S, Chen Y
. Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study. BMC Nephrol. 2019; 20(1):297.
PMC: 6683466.
DOI: 10.1186/s12882-019-1488-6.
View
2.
Stefan G, Mircescu G
. Hydroxychloroquine in IgA nephropathy: a systematic review. Ren Fail. 2021; 43(1):1520-1527.
PMC: 8604447.
DOI: 10.1080/0886022X.2021.2000875.
View
3.
Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T
. Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol. 2008; 19(12):2384-95.
PMC: 2588104.
DOI: 10.1681/ASN.2007121311.
View
4.
. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021; 100(4S):S1-S276.
DOI: 10.1016/j.kint.2021.05.021.
View
5.
Liu L, Yang Y, Shi S, Bao Y, Yang C, Zhu S
. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial. Am J Kidney Dis. 2019; 74(1):15-22.
DOI: 10.1053/j.ajkd.2019.01.026.
View